<DOC>
	<DOCNO>NCT02777021</DOCNO>
	<brief_summary>Treatment pediatric acute myeloid leukemia ( AML ) involve intensive chemotherapy regimens result period profound neutropenia leave patient susceptible severe infectious complication . Infectious complication lead cause treatment related mortality among AML patient , little clinical data inform whether management neutropenia post AML chemotherapy occur outpatient inpatient set . Further , study conduct assess impact neutropenia management strategy quality life pediatric patient AML caregiver .</brief_summary>
	<brief_title>Home Away From Home - Quality Life Surveys</brief_title>
	<detailed_description>This prospective observational cohort study , primary objective study compare patient caregiver quality life patient-centered outcome inpatient versus outpatient management neutropenia child AML . Local study investigator ( pediatric oncologist study coordinator ) thirteen participate pediatric institution communicate weekly basis inpatient leukemia service identify AML patient potentially eligible study enrollment . Once identify , study personnel review patient study eligibility criterion . Three visit patient caregiver occur : screening visit , initial survey visit , follow-up visit . Screening Visit : Patients interested study approach consent initiation course chemotherapy . After informed consent/assent obtain completion chemotherapy course , eligibility criterion participation confirm prior study inclusion . Visit 1 occur prior last day chemotherapy administration course . This visit include : - Brief survey capture covariates unavailable medical record - A baseline health-related quality life ( HRQOL ) survey Surveys administer via tablet computer last total 15-30 minute per respondent . In case child 5 year age old , child self-report parent proxy-report scale separately administer child caregiver , respectively . If child 5 year age , parent-proxy version administer . Visit 2 occur prior start subsequent course chemotherapy . This visit include : - A follow-up HRQOL survey - Patient-centered outcome survey develop previously qualitative interview AML patient caregiver Surveys administer via tablet computer last total 15-30 minute per respondent . In case child 5 year age old , child self-report parent proxy-report scale administer child caregiver , respectively . If child 5 year age , parent-proxy version administer . We provide $ 50 gift card child-parent dyad upon completion follow-up quality life survey .</detailed_description>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>1 . Participants enrol patientcaregiver dyad . The patient must : Between 0 18 year age diagnosis , inclusive . Patient English Spanish literate . Receiving chemotherapy AML June 1 , 2016 December 31 , 2018 . 2 . Participants enrol patientcaregiver dyad . The caregiver must : English Spanish literate . The legal guardian patient receive chemotherapy AML June 1 , 2016 December 31 , 2018 . 3 . Parental/caregiver inform consent , appropriate , child assent . There exclusion criterion protocol . All patient meet inclusion criterion contribute data .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pediatric</keyword>
	<keyword>Acute Myeloid Leukemia</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Neutropenia Management</keyword>
	<keyword>Patient Centered Outcomes</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>